Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Agenus Announces Updated Phase 1 Data and Progress On BOT/BAL Development In Metastatic MSS Colorectal Cancer, Updated Phase 1 Data Demonstrate 12-Month Overall Survival (OS) Of 71% And 18-Month OS Of 62%

Author: Benzinga Newsdesk | April 12, 2024 07:32am

Company plans to discuss encouraging Phase 2 interim results with the FDA

Company plans to submit Phase 2 data to a major medical conference in the second half of 2024

Posted In: AGEN